News
In Childhood Cancer, Private Insurance Means Better Survival
Children and young adults with pediatric cancer are less likely to be alive five and 10 years following diagnosis if their health insurance is covered by Medicaid or other government agencies, compared to those with private insurance, according to researchers at UCSF Benioff Children’s Hospitals. In
E-Cigarettes Significantly Raise Risk of Chronic Lung Disease, First Long-Term Study Finds
E-cigarette use significantly increases a person’s risk of developing chronic lung diseases like asthma, bronchitis, emphysema or chronic obstructive pulmonary disease, according to new UC San Francisco research, the first longitudinal study linking e-cigarettes to respiratory illness in a sample
Researchers Halt Spread of Breast Cancer by Blocking Metastasis-Promoting Enzyme
In a breakthrough with important implications for the future of immunotherapy for breast cancer, UC San Francisco scientists have found that blocking the activity of a single enzyme can prevent a common type of breast cancer from spreading to distant organs. While studying a mouse model that
ACS and NCI Honor Ruggero for Bold Work in Cancer Research
In the past 90 days, Davide Ruggero, PhD, Professor of Urology and cancer center member, has accomplished the rare feat of receiving two of the most competitive awards available to cancer scientists. In September, the American Cancer Society awarded Ruggero a prestigious ACS Professorship Award; and
Innovating for Cancer Care in Africa: Global Cancer Program at the AORTIC Cancer Research Conference in Mozambique
Members of UCSF's Global Cancer Program attended the 12th International Conference on Cancer in Africa November 5-8, 2019 in Maputo, Mozambique. More than two thousand participants from all over the world attended the 2019 African Organisation for Research and Training in Cancer (AORTIC) conference
Two from UCSF Recognized as 2019 STAT Wunderkinds
Two UCSF clinicians were recognized on STAT's 2019 Wonderkind list, which includes the most impressive doctors and researchers early in their careers. Over the past several months, a team of STAT editors and reporters pored through hundreds of nominations from across North America, on the hunt for
HDFCCC Receives U54 Award from National Cancer Institute to Reduce HPV-Associated Cancers in Latin America
The Global Cancer Program at HDFCCC received a U54 award for a partnership with Mexico and Puerto Rico to reduce the risk of HPV-associated cancers in HIV-infected individuals in Latin America. The Global Cancer Program will partner with the National Cancer Institute and National Institute of Public